Long-term clinical outcomes of combined modality therapy for advanced-stage Hodgkin lymphoma in the PET era: A retrospective study

CONCLUSIONS: Individuals with advanced-stage HL treated with anthracycline-based chemotherapy (anthracycline-based chemotherapy with doxorubicin, bleomycin, vinblastine and dacarbazine regimen) and CRT had excellent long-term outcomes. As isolated infield failures are uncommon, selective consolidation with conformal RT to high-risk sites improves final disease outcomes.PMID:38577858 | DOI:10.4103/ijmr.ijmr_3459_21

Source: Indian J Med Res - April 5, 2024 Category: Research Authors: Swati Chugh Goutam Panda Smruti Mokal Hasmukh Jain Bhausaheb Bagal Nehal Khanna Sridhar Epari Sachin Punatar Lingaraj Nayak Anant Gokarn Naveen Khattry Manju Sengar Siddhartha Laskar Jayant S Goda Source Type: research